| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/30/2009 | WO2009093650A1 Prostaglandin-containing fat emulsion and method for producing the same |
| 07/30/2009 | WO2009093540A1 Chlorine dioxide liquid preparation composition |
| 07/30/2009 | WO2009093250A2 Targeting of innate immune response to tumor site |
| 07/30/2009 | WO2009093072A1 Vaccine composition |
| 07/30/2009 | WO2009092954A1 Composition containing a retinoid and dispersed benzoyle peroxide |
| 07/30/2009 | WO2009092754A1 Composition comprising protein and disperse fat |
| 07/30/2009 | WO2009092601A1 Pharmaceutical dosage form |
| 07/30/2009 | WO2009092387A2 Pharmaceutical composition containing a garlic extract |
| 07/30/2009 | WO2009092291A1 A drug delivery system, its preparation process and use |
| 07/30/2009 | WO2009067536A3 Formulation for decreasing tobacco, alcohol, drug or food consumption |
| 07/30/2009 | WO2009067175A3 Oligomer-dantrolene conjugates and related compounds |
| 07/30/2009 | WO2009064460A3 Gastrointestinal delivery systems |
| 07/30/2009 | WO2009062136A3 Controlled delivery of insulin from thermo-sensitive polymer solution |
| 07/30/2009 | WO2009056322A3 Foam stabilizer for a sterilization composition |
| 07/30/2009 | WO2009024771A3 Materials and methods for treating cancers which express folate receptors |
| 07/30/2009 | WO2008151150A3 Peg-pei copolymers for nucleic acid delivery |
| 07/30/2009 | WO2008147438A3 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules |
| 07/30/2009 | WO2008101700A3 Bispecific fusion protein having therapeutic and diagnostic potential |
| 07/30/2009 | WO2008089771A8 Dna controlled assembly of lipid membranes |
| 07/30/2009 | WO2008070384A3 Method of preparing macromolecular contrast agents and uses thereof |
| 07/30/2009 | US20090192513 Resorbable ceramic compositions |
| 07/30/2009 | US20090192320 a polyalkylene glycol derivative having a reactive group, which can be combined with a bio-related substance, at the primary carbon at the 1-position of a glycerin skeleton and having polyalkylene glycol chains at the 2- and 3-positions |
| 07/30/2009 | US20090192233 Cosmetic or pharmaceutical preparation |
| 07/30/2009 | US20090192232 Supplementary Food Composition For Reducing Body Odor |
| 07/30/2009 | US20090192214 Drug delivery from rapid gelling polymer composition |
| 07/30/2009 | US20090192205 Process for release of biologically active species |
| 07/30/2009 | US20090192132 Pharmaceutical Composition |
| 07/30/2009 | US20090192131 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192093 Abuse-resistant amphetamine prodrugs |
| 07/30/2009 | US20090192091 Peptide inhibitors of protein kinase C |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090191624 Use of transthyretin peptide/protein fussions to increase the serum half-life of pharmacologically active peptides/proteins |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191271 Topical Formulations |
| 07/30/2009 | US20090191266 Pregelatinized Starch In A Controlled Release Formulation |
| 07/30/2009 | US20090191261 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 07/30/2009 | US20090191233 Influenza antigen delivery vectors and constructs |
| 07/30/2009 | US20090191231 Prevention and treatment of amyloidogenic disease |
| 07/30/2009 | US20090191227 Compositions and Methods for Enhancing Immune Responses to Vaccines |
| 07/30/2009 | US20090191226 Adjuvant formulation comprising a submicron oil droplet emulsion |
| 07/30/2009 | US20090191200 Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity |
| 07/30/2009 | US20090191121 Targeting and Imaging Tumor Vasculature Using Conjugates That Bind to Aminophospholipids |
| 07/30/2009 | US20090188491 Medicaments |
| 07/30/2009 | DE4245089B4 Oral pharmaceutical compsn. for treating hyperlipoproteinaemia or atherosclerosis - comprises hydroxymethyl glutaryl coenzyme A reductase cholesterol inhibitor |
| 07/30/2009 | CA2713137A1 Targeting of innate immune response to tumor site |
| 07/30/2009 | CA2713128A1 Pharmaceutical dosage form |
| 07/30/2009 | CA2712731A1 Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief |
| 07/30/2009 | CA2712446A1 Composition comprising protein and disperse fat |
| 07/30/2009 | CA2710745A1 Composition comprenant un retinoide et du peroxyde de benzoyle disperse |
| 07/29/2009 | EP2082751A2 Topical formulations in the form of aqueous gels fro the treatment of disorders of the skin and mucous membranes or as vehicules for transdermal administration of natural extractive preparations, substances, molecules and drugs |
| 07/29/2009 | EP2082748A1 Agent preparations and medicine capable of generating and containing thrombin |
| 07/29/2009 | EP2082747A2 Treatment for Alzeimer's disease |
| 07/29/2009 | EP2082737A2 Methods of inducing terminal differentiation |
| 07/29/2009 | EP2082734A2 Temperature-sensitive nano-carriers |
| 07/29/2009 | EP2081965A1 Method for preparing cyclodextrin oligomers or polymers, products obtained and uses |
| 07/29/2009 | EP2081964A2 Alginate and alginate lyase compositions and methods of use |
| 07/29/2009 | EP2081958A1 Peptide extended insulins |
| 07/29/2009 | EP2081957A1 Peg modified exendin or exendin analog and compositions and use thereof |
| 07/29/2009 | EP2081602A2 Toxin peptide therapeutic agents |
| 07/29/2009 | EP2081601A1 Dendrimeric platform for controlled release of drugs |
| 07/29/2009 | EP2081553A2 Stable antibody formulations |
| 07/29/2009 | EP2081551A1 Dried reconstituted vesicle formation for pharmaceutical application |
| 07/29/2009 | EP2081549A2 Ophthalmic compositions containing diglycine |
| 07/29/2009 | EP2081547A2 Galenic form for the trans-mucosal delivery of active ingredients |
| 07/29/2009 | EP2005990A9 Microneedle device and transdermal administration device provided with microneedles |
| 07/29/2009 | EP1883390B1 Topical compositions |
| 07/29/2009 | EP1711170B1 Transdermal delivery device for dihydropyridine type calcium antagonists containing two fatty acids |
| 07/29/2009 | EP1624896B1 Method for the production of a stable injectable formulation made of paclitaxel |
| 07/29/2009 | EP1435910B1 Novel cyclosporin analog microemulsion preconcentrates |
| 07/29/2009 | EP1411895B2 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1401473B1 Transporters comprising spaced arginine moieties |
| 07/29/2009 | EP1278494B1 Device and method for treating urinary incontinence in females |
| 07/29/2009 | EP1260215B1 Rapidly disintegrable tablet containing polyvinyl alcohol |
| 07/29/2009 | EP1189641B1 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 07/29/2009 | EP1073463B1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 07/29/2009 | EP0879048B2 Method for making tablets using trehalose |
| 07/29/2009 | EP0854726B2 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 07/29/2009 | CN101495155A New protein conjugates and methods for their preparation |
| 07/29/2009 | CN101495154A Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same |
| 07/29/2009 | CN101495153A Drug delivery system based on regioselectively amidated hyaluronic acid |
| 07/29/2009 | CN101495152A Preparation of polymer conjugates of vla-4 antagonists via a mitsunobu' s reaction |
| 07/29/2009 | CN101495151A Targeted therapy |
| 07/29/2009 | CN101495150A Pharmaceutical composition improved in absorption of pharmacologically active substance |
| 07/29/2009 | CN101495149A PEG-polyacetal diblock and triblock copolymers and pharmaceutical compositions |
| 07/29/2009 | CN101491682A PEG-IFN omega conjugate and preparation technique thereof |
| 07/29/2009 | CN101491681A Medicine containing PEG human growth hormone conjugate and use thereof |
| 07/29/2009 | CN101491680A Infectious bursal disease live-vaccine heat-proof freeze-dry protectant and preparation method thereof |
| 07/29/2009 | CN101491679A Soft-capsule coating method |
| 07/29/2009 | CN101491678A Preparation method of injector using tween-80 as solubilizer |
| 07/29/2009 | CN101491677A Method for preparing medicine composite with reduced bitter |
| 07/29/2009 | CN101491676A Ibuprofen compositions |
| 07/29/2009 | CN101491520A Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 07/29/2009 | CN100519643C Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from |
| 07/29/2009 | CN100519581C Interferon-beta composite |
| 07/29/2009 | CN100519513C Chloramineone and haptene, immuongen, antibody and coupler of its metabolite |
| 07/29/2009 | CN100518832C Kidney target precursor medicine, said prepn., its preparing method and application |
| 07/29/2009 | CN100518831C Solid nano-medicine and preparing method thereof |
| 07/29/2009 | CN100518830C Targeted, control-release and thin film coating material made of denatured starch for oral medicine to treat colonic diseases, its prepn. method and application of manufacturing the coating material |